138 related articles for article (PubMed ID: 29807145)
1. Raloxifene, a promising estrogen replacement, limits TDP-25 cell death by enhancing autophagy and suppressing apoptosis.
Zhou F; Dong H; Liu Y; Yan L; Sun C; Hao P; Liu Y; Zhai J; Liu Y
Brain Res Bull; 2018 Jun; 140():281-290. PubMed ID: 29807145
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective action of raloxifene against hypoxia-induced damage in mouse hippocampal cells depends on ERα but not ERβ or GPR30 signalling.
Rzemieniec J; Litwa E; Wnuk A; Lason W; Gołas A; Krzeptowski W; Kajta M
J Steroid Biochem Mol Biol; 2015 Feb; 146():26-37. PubMed ID: 24846829
[TBL] [Abstract][Full Text] [Related]
3. Valproate Attenuates 25-kDa C-Terminal Fragment of TDP-43-Induced Neuronal Toxicity via Suppressing Endoplasmic Reticulum Stress and Activating Autophagy.
Wang X; Ma M; Teng J; Che X; Zhang W; Feng S; Zhou S; Zhang Y; Wu E; Ding X
Int J Biol Sci; 2015; 11(7):752-61. PubMed ID: 26078717
[TBL] [Abstract][Full Text] [Related]
4. Estrogen and the selective estrogen receptor modulator (SERM) protection against cell death in estrogen receptor alpha and beta expressing U2OS cells.
Kallio A; Guo T; Lamminen E; Seppänen J; Kangas L; Väänänen HK; Härkönen P
Mol Cell Endocrinol; 2008 Jul; 289(1-2):38-48. PubMed ID: 18455292
[TBL] [Abstract][Full Text] [Related]
5. Raloxifene induces cell death and inhibits proliferation through multiple signaling pathways in prostate cancer cells expressing different levels of estrogen receptor α and β.
Rossi V; Bellastella G; De Rosa C; Abbondanza C; Visconti D; Maione L; Chieffi P; Della Ragione F; Prezioso D; De Bellis A; Bellastella A; Sinisi AA
J Cell Physiol; 2011 May; 226(5):1334-9. PubMed ID: 20945400
[TBL] [Abstract][Full Text] [Related]
6. Apoptotic action of 17beta-estradiol in raloxifene-resistant MCF-7 cells in vitro and in vivo.
Liu H; Lee ES; Gajdos C; Pearce ST; Chen B; Osipo C; Loweth J; McKian K; De Los Reyes A; Wing L; Jordan VC
J Natl Cancer Inst; 2003 Nov; 95(21):1586-97. PubMed ID: 14600091
[TBL] [Abstract][Full Text] [Related]
7. SecinH3 Attenuates TDP-43 p.Q331K-Induced Neuronal Toxicity by Suppressing Endoplasmic Reticulum Stress and Enhancing Autophagic Flux.
Hu W; Liu X; Wang S; Sun G; Zhao R; Lu H
IUBMB Life; 2019 Feb; 71(2):192-199. PubMed ID: 30376609
[TBL] [Abstract][Full Text] [Related]
8. Estradiol and selective estrogen receptor modulators differentially regulate target genes with estrogen receptors alpha and beta.
Tee MK; Rogatsky I; Tzagarakis-Foster C; Cvoro A; An J; Christy RJ; Yamamoto KR; Leitman DC
Mol Biol Cell; 2004 Mar; 15(3):1262-72. PubMed ID: 14699072
[TBL] [Abstract][Full Text] [Related]
9. Apoptosis induction in human breast cancer cell lines by synergic effect of raloxifene and resveratrol through increasing proapoptotic genes.
Mirzapur P; Khazaei MR; Moradi MT; Khazaei M
Life Sci; 2018 Jul; 205():45-53. PubMed ID: 29705353
[TBL] [Abstract][Full Text] [Related]
10. Tdp-25 Routing to Autophagy and Proteasome Ameliorates its Aggregation in Amyotrophic Lateral Sclerosis Target Cells.
Cicardi ME; Cristofani R; Rusmini P; Meroni M; Ferrari V; Vezzoli G; Tedesco B; Piccolella M; Messi E; Galbiati M; Boncoraglio A; Carra S; Crippa V; Poletti A
Sci Rep; 2018 Aug; 8(1):12390. PubMed ID: 30120266
[TBL] [Abstract][Full Text] [Related]
11. Raloxifene inhibits adipose tissue inflammation and adipogenesis through Wnt regulation in ovariectomized rats and 3 T3-L1 cells.
Shen HH; Yang CY; Kung CW; Chen SY; Wu HM; Cheng PY; Lam KK; Lee YM
J Biomed Sci; 2019 Aug; 26(1):62. PubMed ID: 31470850
[TBL] [Abstract][Full Text] [Related]
12. Raloxifene-stimulated experimental breast cancer with the paradoxical actions of estrogen to promote or prevent tumor growth: a unifying concept in anti-hormone resistance.
Balaburski GM; Dardes RC; Johnson M; Haddad B; Zhu F; Ross EA; Sengupta S; Klein-Szanto A; Liu H; Lee ES; Kim H; Jordan VC
Int J Oncol; 2010 Aug; 37(2):387-98. PubMed ID: 20596666
[TBL] [Abstract][Full Text] [Related]
13. Raloxifene, a selective estrogen receptor modulator, induces mitochondria-mediated apoptosis in human endometrial carcinoma cells.
Morishima S; Shibata MA; Ohmichi M; Otsuki Y
Med Mol Morphol; 2008 Sep; 41(3):132-8. PubMed ID: 18807138
[TBL] [Abstract][Full Text] [Related]
14. Effects of ospemifene, a novel selective estrogen-receptor modulator, on human breast tissue ex vivo.
Eigeliene N; Kangas L; Hellmer C; Kauko T; Erkkola R; Härkönen P
Menopause; 2016 Jul; 23(7):719-30. PubMed ID: 27163517
[TBL] [Abstract][Full Text] [Related]
15. Raloxifene decreases cell viability and migratory potential in prostate cancer cells (LNCaP) with GPR30/GPER1 involvement.
Salata GC; Pinho CF; de Freitas ATAG; Aquino AM; Justulin LA; Mendes LO; Gonçalves BF; Delella FK; Scarano WR
J Pharm Pharmacol; 2019 Jul; 71(7):1065-1071. PubMed ID: 30919959
[TBL] [Abstract][Full Text] [Related]
16. Estrogens activate bone morphogenetic protein-2 gene transcription in mouse mesenchymal stem cells.
Zhou S; Turgeman G; Harris SE; Leitman DC; Komm BS; Bodine PV; Gazit D
Mol Endocrinol; 2003 Jan; 17(1):56-66. PubMed ID: 12511606
[TBL] [Abstract][Full Text] [Related]
17. Impact of the selective estrogen receptor modulator, raloxifene, on neuronal survival and outgrowth following toxic insults associated with aging and Alzheimer's disease.
O'Neill K; Chen S; Brinton RD
Exp Neurol; 2004 Jan; 185(1):63-80. PubMed ID: 14697319
[TBL] [Abstract][Full Text] [Related]
18. Selective estrogen receptor modulators: discrimination of agonistic versus antagonistic activities by gene expression profiling in breast cancer cells.
Frasor J; Stossi F; Danes JM; Komm B; Lyttle CR; Katzenellenbogen BS
Cancer Res; 2004 Feb; 64(4):1522-33. PubMed ID: 14973112
[TBL] [Abstract][Full Text] [Related]
19. Estrogen and selective estrogen receptor modulators exert neuroprotective effects and stimulate the expression of selective Alzheimer's disease indicator-1, a recently discovered antiapoptotic gene, in human neuroblast long-term cell cultures.
Benvenuti S; Luciani P; Vannelli GB; Gelmini S; Franceschi E; Serio M; Peri A
J Clin Endocrinol Metab; 2005 Mar; 90(3):1775-82. PubMed ID: 15585566
[TBL] [Abstract][Full Text] [Related]
20. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].
Zhang YX; Kong CZ
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):271-5. PubMed ID: 18361842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
